COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LN1Z
|
|||
Drug Name |
Methylprednisolone
|
|||
Synonyms |
Depo-medrol; M-predrol; Medrol; Medrol Acetate
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 3 | [1] | |
Other Indication | Rheumatoid arthritis | Approved | [2] | |
Therapeutic Class |
Antiviral Agents
|
|||
Company |
Pharmacia And Upjohn Co
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H30O5
|
|||
Canonical SMILES |
CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
|
|||
InChI |
1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1
|
|||
InChIKey |
VHRSUDSXCMQTMA-PJHHCJLFSA-N
|
|||
CAS Number |
CAS 83-43-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
82706, 811679, 855789, 7847473, 7979947, 8154374, 10321588, 11406050, 11466307, 11467427, 11486113, 12159225, 14779784, 14853277, 24870169, 24896564, 29225690, 46504885, 47440566, 47589248, 48259526, 48334797, 48416259, 49698417, 50019481, 50104073, 50139236, 50796061, 53790220, 56311264, 56311302, 56311303, 56311483, 56312634, 56313960, 56313963, 56314026, 56314034, 56424125, 57323679, 57650805, 81093211, 85300841, 85788445, 87560014, 92125124, 92309029, 93576705, 103189214, 103914078
|
|||
ChEBI ID |
CHEBI:6888
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04341038) Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury | |||
2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.